Brazil and China are studying a new bi-oceanic railway. Could this massive project reshape South American trade and cut ...
Genmab A/S (Nasdaq: GMAB) today announced topline results from the Phase 3 EPCORE DLBCL-4 trial evaluating the combination of fixed duration epcoritamab, a T-cell engaging bispecific antibody ...
Topline results from Phase 3 EPCORE DLBCL-4 trial evaluating epcoritamab in combination with lenalidomide demonstrated statistically significant and clinically meaningful improvement in progression-fr ...
For the first time, Medicare will cover GLP-1 drugs prescribed solely for weight loss for eligible beneficiaries at a $50 ...
Two of the hottest trends in health — longevity medicine and weight loss drugs — are colliding. A theory that GLP-1 ...
In 2024, I flew on a microgravity, or zero G, parabolic flight with the European Space Agency (ESA). The aeroplane flew big arcs up and down in the sky. At the top of the arc I experienced 22 seconds ...
Health systems preparing Medicare GLP-1 Bridge program focus on staff education, prior authorization, and workflow coordination ahead of July 1 launch.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results